Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus

Journal of Physiology

Volumn 578, Issue 1, 2007, Pages 233-247

  Neu, Axel ^a   Földy, Csaba ^a   Soltesz, Ivan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; CANNABINOID 1 RECEPTOR; CHOLECYSTOKININ; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; METABOTROPIC RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVOKED RESPONSE; HIPPOCAMPUS; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE ENDING; NEUROMODULATION; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC INHIBITION; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; AMPLITUDE MODULATION; BASKET CELL; CALCIUM TRANSPORT; FREQUENCY MODULATION; HIPPOCAMPAL CA1 REGION; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; PROTEIN EXPRESSION; SPIKE WAVE;

ANIMALS; CHOLECYSTOKININ; ELECTROPHYSIOLOGY; ENDOCANNABINOIDS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEURONS; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GABA-B; RECEPTORS, OPIOID; RECEPTORS, SEROTONIN; SYNAPSES;

EID: 33845806871     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.115691     Document Type: Article

References (47)

1. Bartos M, Vida I, Frotscher M, Meyer A, Monyer H, Geiger JR & Jonas P (2002). Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks. Proc Natl Acad Sci U S A 99, 13222-13227.
2. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M et al. (1997). A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272, 22330-22339.
3. Buhl EH, Cobb SR, Halasy K & Somogyi P (1995). Properties of unitary IPSPs evoked by anatomically identified basket cells in the rat hippocampus. Eur J Neurosci 7, 1989-2004.
4. Chen K, Ratzliff A, Hilgenberg L, Gulyas A, Freund TF, Smith M, Dinh TP, Piomelli D, Mackie K & Soltesz I (2003). Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39, 599-611.
5. Cobb SR, Buhl EH, Halasy K, Paulsen O & Somogyi P (1995). Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378, 75-78.
6. Cope DW, Maccaferri G, Marton LF, Roberts JD, Cobden PM & Somogyi P (2002). Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 109, 63-80.
7. Drake CT & Milner TA (1999). Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res 849, 203-215.
8. Ferezou I, Cauli B, Hill EL, Rossier J, Hamel E & Lambolez B (2002). 5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons. J Neurosci 22, 7389-7397.
9. Földy C, Neu A, Jones MV & Soltesz I (2006). Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26, 1465-1469.
10. Freund TF (2003). Interneuron diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci 26, 489-495.
11. Fricker D & Miles R (2000). EPSP amplification and the precision of spike timing in hippocampal neurons. Neuron 28, 559-569.
12. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T & Kano M (2004). Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19, 2682-2692.
13. Glickfeld LL & Scanziani M (2006). Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9, 807-815.
14. Guo J & Ikeda SR (2004). Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65, 665-674.
15. Hajos N, Papp EC, Acsady L, Levey AI & Freund TF (1998). Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 82, 355-376.
16. Hefft S & Jonas P (2005). Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 8, 1319-1328.
17. Hentges ST, Low MJ & Williams JT (2005). Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 25, 9746-9751.
18. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K & Freund TF (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19, 4544-4558.
19. Kim J, Isokawa M, Ledent C & Alger BE (2002). Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22, 10182-10191.
20. Klausberger T, Marton LF, O'Neill J, Huck JH, Dalezios Y, Fuentealba P et al. (2005). Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci 25, 9782-9793.
21. Kreitzer AC & Regehr WG (2001). Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21, RC174.
22. Lambert NA & Wilson WA (1993). Heterogeneity in presynaptic regulation of GABA release from hippocampal inhibitory neurons. Neuron 11, 1057-1067.
23. Llano I, Leresche N & Marty A (1991). Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6, 565-574.
24. Losonczy A, Biro AA & Nusser Z (2004). Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A 101, 1362-1367.
25. McBain CJ & Fisahn A (2001). Interneurons unbound. Nat Rev Neurosci 2, 11-23.
26. Maejima T, Hashimoto K, Yoshida T, Aiba A & Kano M (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31, 463-475.
27. Mann EO, Suckling JM, Hajos N, Greenfield SA & Paulsen O (2005). Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro. Neuron 45, 105-117.
28. Miles R, Toth K, Gulyas AI, Hajos N & Freund TF (1996). Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16, 815-823.
29. Nyiri G, Cserep C, Szabadits E, Mackie K & Freund TF (2005). CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136, 811-822.
30. Ohno-Shosaku T, Hashimotodani Y, Maejima T & Kano M (2005). Calcium signaling and synaptic modulation: Regulation of endocannabinoid-mediated synaptic modulation by calcium. Cell Calcium 38, 369-374.
31. Ohno-Shosaku T, Maejima T & Kano M (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738.
32. Pan X, Ikeda SR & Lewis DL (1998). SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Caaneuυci.edu; currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54, 1064-1072.
33. Pawelzik H, Hughes DI & Thomson AM (2002). Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. J Comp Neurol 443, 346-367.
34. Pertwee RG (2005). Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 76, 1307-1324.
35. Pitler TA & Alger BE (1992). Postsynaptic spike firing reduces synaptic GABA A responses in hippocampal pyramidal cells. J Neurosci 12, 4122-4132.
36. Pouille F & Scanziani M (2001). Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition. Science 293, 1159-1163.
37. Schmitz D, Empson RM & Heinemann U (1995). Serotonin and 8-OH-DPAT reduce excitatory transmission in rat hippocampal area CA1 via reduction in presumed presynaptic Caaneuυci.edu; entry. Brain Res 701, 249-254.
38. Seeger T, Fedorova I, Zheng F, Miyakawa T, Koustova E, Gomeza J, Basile AS, Alzheimer C & Wess J (2004). M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 24, 10117-10127.
39. Sloviter RS, Ali-Akbarian L, Elliott RC, Bowery BJ & Bowery NG (1999). Localization of GABA(B) (R1) receptors in the rat hippocampus by immunocytochemistry and high resolution autoradiography, with specific reference to its localization in identified hippocampal interneuron subpopulations. Neuropharmacology 38, 1707-1721.
40. Soltesz I (2005). Diversity in the Neuronal Machine. Oxford University Press, New York.
41. Somogyi P & Klausberger T (2005). Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol 562, 9-26.
42. Varma N, Carlson GC, Ledent C & Alger BE (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21, RC188.
43. Vasquez C & Lewis DL (1999). The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J Neurosci 19, 9271-9280.
44. Vreugdenhil M, Jefferys JG, Celio MR & Schwaller B (2003). Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J Neurophysiol 89, 1414-1422.
45. Wallace MJ, Blair RE, Falenski KW, Martin BR & DeLorenzo RJ (2003). The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307, 129-137.
46. Wilson RI & Nicoll RA (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
47. Zhu PJ & Lovinger DM (2005). Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J Neurosci 25, 6199-6207.